0001415889-22-002300.txt : 20220303
0001415889-22-002300.hdr.sgml : 20220303
20220303161716
ACCESSION NUMBER: 0001415889-22-002300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOTSON JERROLD DUANE
CENTRAL INDEX KEY: 0001388853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 22708987
MAIL ADDRESS:
STREET 1: 5 CENTERPOINTE DRIVE
STREET 2: SUITE 400
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-03032022_010304.xml
X0306
4
2022-03-01
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001388853
DOTSON JERROLD DUANE
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
VP, CFO AND SECRETARY
Stock Option (Right to Buy)
1.37
2022-03-01
4
A
0
150000
0
A
2032-03-01
Common Stock
150000
150000
D
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan. Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.
/s/ Jerrold D. Dotson
2022-03-03